<DOC>
	<DOCNO>NCT02910297</DOCNO>
	<brief_summary>The purpose study determine cannabidiol ( CBD ) obtain via state Minnesota reduce seizures patient severe intractable epilepsy ( Dravet Syndrome Lennox Gastaut Syndrome ) , measure blood level CBD help determine CBD concentration-response characteristic .</brief_summary>
	<brief_title>The Pharmacokinetics Cannabidiol ( CBD ) Its Effects Children With Severe Epilepsy</brief_title>
	<detailed_description>Patients medically refractory epilepsy register take CBD State Minnesota offer opportunity participate study . If consent participation obtain , patient ( likely , patient 's guardian ) ask begin seizure diary least 7-day period prior ( ideally , long ) receive CBD , continue track seizure throughout study . Upon receipt CBD Minnesota dispensary , subject take CBD direct return clinic repeat visit ( part standard care ) occur 2-8 week continual use CBD . During clinic visit , patient undergo blood draw monitor prescribed AED concentration part standard care . In addition standard blood draw , research participant ask provide blood sample 5 ml measure CBD concentration . As patient instructed take CBD two hour prior standard care AEDs , clinical experience indicate patient take CBD quite early morning ( around 6 AM ) . Thus , time sample collection record hour post-dose , likely nearer peak serum concentration . If study participant indwell intravenous access port , ask provide additional sample 5 ml least one hour initial sample . During repeat visit , subject ask continue document seizure activity seizure diary continue CBD treatment . Any change AEDs administer concurrently CBD also record . Subjects already stable regimen CBD also eligible participate . At clinic visit , ask provide blood sample 5 ml , time sample record hour post-dose CBD . They also ask begin seizure diary continue track seizure activity . If patient terminates CBD treatment , ask continue track seizure activity last CBD dose follow-up clinic visit , determine change seizure activity CBD .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<mesh_term>Epilepsies , Myoclonic</mesh_term>
	<criteria>Diagnosed Dravet Syndrome LennoxGastaut Syndrome Patients plan obtain medical cannabidiol Patients already take medical cannabidiol planning stop taking . Patients without diagnosis Dravet syndrome LennoxGastaut syndrome</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cannabidiol</keyword>
	<keyword>Dravet Syndrome</keyword>
	<keyword>Lennox Gastaut Syndrome</keyword>
</DOC>